Description
Genetic variants have been found to cause epilepsy as well as affect how people respond to treatment. Whole exome sequencing is a new method of genetic testing that has the advantage of being able to screen all the genes in a person. Currently it is mainly being used for research purposes. The purpose of this prospective study is to find out whether genomic sequencing offers value for money when used in the clinical setting to help diagnose people with epilepsy.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
bioinformatics, genetics, mathematics, epilepsy, sequencing, physiology, pharmacology, microbiology, anatomy, developmental biology, molecular biology, biochemistry, immunology, human pathology, clinical, neuroscience
School
School of Translational Medicine » Neuroscience
Available options
PhD/Doctorate
Masters by research
Honours
BMedSc(Hons)
Time commitment
Full-time
Top-up scholarship funding available
No
Physical location
Alfred Research Alliance
Co-supervisors
Dr
Alison Anderson